Back to search

Article

Treatment of left ventricular dysfunction in dilated cardiomyopathy with a myeloperoxidase inhibitor

2022-11-08

Abstract excerpt

Dilated cardiomyopathy (DCM), an incurable disease of the cardiomyocyte terminating in systolic heart failure (HFrEF), is prevalent, causes hospitalization and is associated with increased mortality. Despite evidence of immune activation in DCM, anti-inflammatory interventions so far did not prove to alter the course of this disease. Here we show that myeloperoxidase (MPO), the principal heme peroxidase expressed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c035e46d-f626-5379-8d10-c4a1eab7cfcf
DOI
10.1101/2022.11.02.22281785
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Treatment of left ventricular dysfunction in dilated cardiomyopathy with a myeloperoxidase inhibitorDOI 10.1101/2022.11.02.22281785
Select a neighboring publication to make it the new centre.